(Q43583148)

English

Pre-emptive therapy against cytomegalovirus (CMV) disease guided by CMV antigenemia assay after allogeneic hematopoietic stem cell transplantation: a single-center experience in Japan

scientific article published in February 2001

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Pre-emptive therapy against cytomegalovirus (CMV) disease guided by CMV antigenemia assay after allogeneic hematopoietic stem cell transplantation: a single-center experience in Japan (English)

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Cytomegalovirus

0 references

Yukio Kobayashi

15

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

author name string

Kanda Y

1

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Mineishi S

2

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Saito T

3

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Seo S

4

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Saito A

5

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Suenaga K

6

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Ohnishi M

7

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Niiya H

8

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Nakai K

9

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Takeuchi T

10

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Kawahigashi N

11

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Shoji N

12

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Ogasawara T

13

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Tanosaki R

14

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Tobinai K

16

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Kami M

17

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Mori S

18

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Suzuki R

19

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Kunitoh H

20

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Takaue Y

21

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

language of work or name

0 references

publication date

1 February 2001

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Bone Marrow Transplantation

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

27

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

437-444

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

A randomized, controlled trial of prophylactic ganciclovir for cytomegalovirus pulmonary infection in recipients of allogeneic bone marrow transplants; The City of Hope-Stanford-Syntex CMV Study Group

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702805

21 January 2018

Rapid immunodiagnosis of active cytomegalovirus infection by monoclonal antibody staining of blood leucocytes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702805

21 January 2018

Increased incidence of cytomegalovirus (CMV) infection and CMV-associated disease after allogeneic bone marrow transplantation from unrelated donors. The Fukuoka Bone Marrow Transplantation Group

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702805

21 January 2018

Strategies for the prevention of cytomegalovirus disease after marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702805

21 January 2018

Comparison of three commercially available monoclonal antibodies directed against pp65 antigen for cytomegalovirus antigenemia assay

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702805

21 January 2018

Ganciclovir prophylaxis to prevent cytomegalovirus disease after allogeneic marrow transplant

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702805

7 January 2021

based on heuristic

inferred from DOI database lookup

Ganciclovir prophylaxis of cytomegalovirus infection and disease in allogeneic bone marrow transplant recipients. Results of a placebo-controlled, double-blind trial

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702805

7 January 2021

based on heuristic

inferred from DOI database lookup

Cytomegalovirus (CMV) antigenaemia for rapid diagnosis and monitoring of CMV-associated disease after bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702805

7 January 2021

based on heuristic

inferred from DOI database lookup

A risk-adapted approach with a short course of ganciclovir to prevent cytomegalovirus (CMV) pneumonia in CMV-seropositive recipients of allogeneic bone marrow transplants

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702805

7 January 2021

based on heuristic

inferred from DOI database lookup

Prevention of CMV disease in allogeneic BMT recipients by cytomegalovirus antigenemia-guided preemptive ganciclovir therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702805

7 January 2021

based on heuristic

inferred from DOI database lookup

Cytomegalovirus pp65 antigenemia-guided pre-emptive treatment with ganciclovir after allogeneic stem transplantation: a single-center experience

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702805

7 January 2021

based on heuristic

inferred from DOI database lookup

Time course analysis of semi-quantitative PCR and antigenaemia assay for prevention of cytomegalovirus disease after bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702805

7 January 2021

based on heuristic

inferred from DOI database lookup

Risk-adapted pre-emptive therapy for cytomegalovirus disease in patients undergoing allogeneic bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702805

7 January 2021

based on heuristic

inferred from DOI database lookup

Factors influencing detection of quantitative cytomegalovirus antigenemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702805

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of commercially available antibody reagents for the cytomegalovirus pp65 antigenemia assay

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702805

7 January 2021

based on heuristic

inferred from DOI database lookup

Early treatment with ganciclovir to prevent cytomegalovirus disease after allogeneic bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702805

7 January 2021

based on heuristic

inferred from DOI database lookup

Prospective evaluation for upper gastrointestinal tract acute graft-versus-host disease after hematopoietic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1702805

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/SJ.BMT.1702805

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43583148&oldid=2206140466"